Developing and Testing a Produce Prescription Implementation Blueprint to Improve Food Security in a Clinical Setting
2 other identifiers
interventional
52
1 country
2
Brief Summary
The goal of this pilot feasibility implementation trial is to assess preliminary feasibility and acceptability of a set of produce prescription implementation strategies. Produce prescription programs are one approach to addressing food insecurity, or the lack of adequate access to safe and nutritious foods. Produce prescriptions involve healthcare providers identifying patients at risk for food insecurity and writing prescriptions for those patients to receive subsidized vegetables. In this study, the investigators will work with a community advisory board to develop a set of enhanced implementation strategies (e.g., training, technical assistance) to support healthcare providers in delivering produce prescription programs. The investigators will assess the feasibility, acceptability, and appropriateness of these strategies. Pre-post changes in implementation outcomes (i.e., adoption) and effectiveness outcomes (i.e., food security) will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 9, 2023
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 31, 2024
May 1, 2024
6 months
June 9, 2023
May 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (26)
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores on each item indicate higher engagement. Scores range from 4-20.
Baseline
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 2
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 4
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 6
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 8
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 10
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 12
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 14
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 16
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 18
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 20
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 22
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 24
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 26
Patient Engagement with the Produce Prescription Program Questionnaire
Patient engagement will be measured with a 4-question biweekly questionnaire that includes items rated on a 5-point (1-5) Likert-scale related to whether patients received the produce and whether they used it and liked it. Higher scores indicate higher engagement. Scores range from 4-20.
Week 28
Acceptability of Intervention Measure
Acceptability of produce prescriptions will be assessed using the 4-item Acceptability of Intervention measure with scores ranging from 1 (completely disagree) to 5 (completely agree). Higher scores indicate higher acceptability of the intervention. Scores range from 4-20.
Baseline
Acceptability of Intervention Measure
Acceptability of produce prescriptions will be assessed using the 4-item Acceptability of Intervention measure with scores ranging from 1 (completely disagree) to 5 (completely agree). Higher scores indicate higher acceptability of the intervention. Scores range from 4-20.
6 month follow up
Feasibility of Intervention Measure
Feasibility of produce prescriptions will be assessed using the 4-item Feasibility of Intervention Measure with scores ranging from 1 (completely disagree) to 5 (completely agree). Higher scores indicate higher feasibility of the intervention. Scores range from 4-20.
Baseline
Feasibility of Intervention Measure
Feasibility of produce prescriptions will be assessed using the 4-item Feasibility of Intervention Measure with scores ranging from 1 (completely disagree) to 5 (completely agree). Higher scores indicate higher feasibility of the intervention. Scores range from 4-20.
6 month follow up
Intervention Appropriateness Measure
Appropriateness of produce prescriptions will be assessed using the 4-item Intervention Appropriateness Measure with scores ranging from 1 (completely disagree) to 5 (completely agree). Higher scores indicate higher appropriateness of the intervention. Scores range from 4-20.
Baseline
Intervention Appropriateness Measure
Appropriateness of produce prescriptions will be assessed using the 4-item Intervention Appropriateness Measure with scores ranging from 1 (completely disagree) to 5 (completely agree). Higher scores indicate higher appropriateness of the intervention. Scores range from 4-20.
6 month follow up
Evidence-Based Practice Attitudes Scale
The Evidence-Based Practice Attitudes Scale measures providers' attitudes toward evidence-based practices - specifically produce prescription programs. Scores range from 0 (not at all) to 4 (to a very great extent); higher scores indicate more positive attitudes toward evidence-based practices. Scores are calculated as an average and range from 0-4.
6-month follow up
Feasibility of Participant Enrollment
Proportion of participants who agree to enroll in the study out of those who are enrolled in the produce prescription program
Baseline
Implementation Climate Scale
This measure of implementation climate will assess the innovation-specific organizational climate for implementing produce prescription programs. Responses will be rated on a 4-point scale ranging from 0 (not at all) to 4 (very great extent). Higher responses indicate a stronger implementation climate. Scores are calculated as an average and range from 0-4.
6 month follow up
Implementation Readiness: Organizational Readiness for Implementing Change
This measure will assess organizations' readiness to implement a new intervention. Responses will be rated on a 5 point scale ranging from 1 (disagree) to 5 (agree). Higher scores indicate higher organizational readiness for change. Scores range from 12-60.
Baseline
Implementation Readiness: Organizational Readiness for Implementing Change
This measure will assess organizations' readiness to implement a new intervention. Responses will be rated on a 5 point scale ranging from 1 (disagree) to 5 (agree). Higher scores indicate higher organizational readiness for change. Scores range from 12-60.
6-month follow up
Secondary Outcomes (9)
Adoption of Produce Prescriptions
Baseline
Adoption of Produce Prescriptions
6 month follow up
Effectiveness: Food Security
Baseline; 6 month follow up
Effectiveness: Food Security
Baseline
Effectiveness: Nutrition security
6 month follow up
- +4 more secondary outcomes
Study Arms (1)
Enhanced Produce Prescription Implementation
EXPERIMENTALThe study team will develop an enhanced implementation blueprint to support uptake of the produce prescription (VeggieRx) intervention that is informed by advisory board input and includes multiple implementation strategies to address identified barriers to implementation.
Interventions
Practices make modifications to their usual produce prescription program based on an implementation blueprint. While the exact implementation strategies to be added will be defined based on qualitative data (data collection in progress), possible implementation strategies may include training or technical assistance.
Eligibility Criteria
You may qualify if:
- years of age or older
- healthcare provider/staff member who makes referrals to produce prescriptions (VeggieRx)
- fluent in English and/or Spanish
You may not qualify if:
- under age 18
- have not been involved in referral process for produce prescriptions (VeggieRx)
- are not fluent in English and/or Spanish
- years of age or older
- enrolled in the produce prescription program (VeggieRx)
- fluent in English and/or Spanish
- under age 18
- declined to enroll in the produce prescription program (VeggieRx)
- are not fluent in English and/or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- Peter G. Peterson Foundationcollaborator
Study Sites (2)
Brown Research on Implementation and Dissemination to Guide Evidence use (BRIDGE) Program
Providence, Rhode Island, 02912, United States
Department of Behavioral and Social Sciences/School of Public Health
Providence, Rhode Island, 02912, United States
Related Publications (1)
Frank HE, Guzman LE, Ayalasomayajula S, Albanese A, Dunklee B, Harvey M, Bouchard K, Vadiveloo M, Yaroch AL, Scott K, Tovar A. Developing and testing a produce prescription implementation blueprint to improve food security in a clinical setting: a pilot study protocol. Pilot Feasibility Stud. 2024 Mar 23;10(1):51. doi: 10.1186/s40814-024-01467-7.
PMID: 38521931BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Hannah E Frank, PhD
Brown University
- PRINCIPAL INVESTIGATOR
Alison Tovar, PhD
Brown University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2023
First Posted
July 12, 2023
Study Start
June 1, 2023
Primary Completion
November 30, 2023
Study Completion
December 31, 2023
Last Updated
May 31, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
Given the small dataset, data will not be made publicly available. However, de-identified quantitative data will be made available to individual investigators following a written request to the study principal investigators.